Inflectra & Off label use

11.9%

of users reported Off label use

91.0%

also reported Severe reaction

70.1%

are women

Severe reaction

91.0%

Hospitalization

8.3%

Death

0.6%

Life-threatening condition

0.1%

Disability

<0.1%

Inflectra: general information

10 - 19 years

1.4%

20 - 29 years

9.8%

30 - 39 years

15.2%

40 - 49 years

17.5%

50 - 59 years

25.7%

60 - 69 years

19.2%

70 - 79 years

10.4%

80 - 89 years

0.8%